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The dopamine D4 receptor (D4R) is predominantly expressed in
the frontal cortex (FC), a brain region that receives dense input
from midbrain dopamine (DA) neurons and is associated with
cognitive and emotional processes. However, the physiological
significance of this dopamine receptor subtype has been diffi-
cult to explore because of the slow development of D4R ago-
nists and antagonists the selectivity and efficacy of which have
been rigorously demonstrated in vivo. We have attempted to
overcome this limitation by taking a multidimensional approach
to the characterization of mice completely deficient in this
receptor subtype. Electrophysiological current and voltage-
clamp recordings were performed in cortical pyramidal neurons
from wild-type and D4R-deficient mice. The frequency of spon-
taneous synaptic activity and the frequency and duration of
paroxysmal discharges induced by epileptogenic agents were
increased in mutant mice. Enhanced synaptic activity was also
observed in brain slices of wild-type mice incubated in the
presence of the selective D4R antagonist PNU-101387G. Con-
sistent with greater electrophysiological activity, nerve terminal
glutamate density associated with asymmetrical synaptic con-
tacts within layer VI of the motor cortex was reduced in mutant
neurons. Taken together, these results suggest that the D4R
can function as an inhibitory modulator of glutamate activity
in the FC.
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Dopamine (DA) modulates multiple neuronal circuits, including
those responsible for the initiation of locomotor activity and the
integration of goal-oriented behaviors, through the stimulation of
five distinct G-protein-coupled receptors (Civelli et al., 1993).
These receptors have been classified as either dopamine D1-like
(D1R and D5R) or D2-like (D2R, D3R, and D4R) according
to similarities in their pharmacological profiles, coupling to sec-
ond messenger systems, nucleotide sequence, and genomic
organization.
One of the major ascending DAergic pathways originates in the
ventral tegmental area and innervates the frontal cortex (FC) in
which DA is thought to play an important role with respect to the
integration of diverse neuronal signals, especially those produced
in response to novel environmental stimuli (Tassin et al., 1980;
Roth et al., 1988; Bardo et al., 1996). It is also in the FC, where
the modulation of neuronal excitability by DA is thought to
contribute to working memory and the establishment of memory
fields (Williams and Goldman-Rakic, 1995). Although there is
considerable evidence suggesting that the D1R plays an important
role in mediating the effects of DA on cognition (Lidow et al.,
1998), little is known about the functional consequences of D2-
like receptor-mediated signaling in the FC.
Among the members of the D2-like receptor family, the D4R
has been of interest since its discovery, in part because it is
densely expressed in the FC (Meador-Woodruff et al., 1996;
Mrzljak et al., 1996; Ariano et al., 1997) and has high affinity for
various atypical antipsychotics (Van Tol et al., 1991; Roth et al.,
1995). Consequently, it has been suggested that the D4R may play
an important role in cognitive functions associated with the
cortex and as such may be involved in the etiology or pathophys-
iology of diseases such as schizophrenia that are thought to
involve altered cortical function. This latter notion is supported
by the demonstration that striatal D4R binding is six times higher
in schizophrenic patients than in normal individuals (Seeman et
al., 1993). At the molecular–genetic level, some alleles of the
highly polymorphic human D4R gene (DRD4) have been associ-
ated with human diseases, social habits, and personality traits,
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including attention deficit hyperactivity disorder (ADHD) (Bark-
ley, 1998; Swanson et al., 1998), opiate and alcohol use (Muramatsu
et al., 1996; Geijer et al., 1997; Kotler et al., 1997), and novelty-
seeking behavior (Benjamin et al., 1996; Ebstein et al., 1996).
In vitro electrophysiological studies have shown that D4Rs can
couple to hyperpolarizing, inwardly rectifying potassium chan-
nels (Werner et al., 1996). Therefore, the activation of the D4R
could play a fundamental role in the overall inhibitory modula-
tion of FC neuronal activity (Starr, 1996; Gulledge and Jaffe,
1998) and may explain, in part, how increased cortical excitability
can be elicited by atypical neuroleptics (D2-like receptor block-
ers) (Menza et al., 1993; Lidow et al., 1998).
Given the demonstration that D4Rs are expressed in the FC of
primates and rats (Meador-Woodruff et al., 1996; Mrzljak et al.,
1996; Ariano et al., 1997), it was of interest to determine whether
the D4R is involved in the modulation of cortical excitability. To
this end we have examined a strain of genetically engineered
mutant mice that lack D4Rs as well as a novel D4R selective
antagonist, PNU-101387G (Merchant et al., 1996). Previously, we
reported that these mutant mice are supersensitive to the psy-
chomotor stimulant effects of ethanol, methamphetamine, and
cocaine (Rubinstein et al., 1997) and that DA synthesis and
turnover are significantly increased in the striatum of these mu-
tants. More recently it has been shown that mice lacking D4Rs
exhibit reduced exploration of novel stimuli (Dulawa et al., 1999).
Herein we present electrophysiological, pharmacological, immu-
nohistochemical, and ultrastructural evidence that the D4R-
deficient mice display cortical hyperexcitability, consistent with
the interpretation that in wild-type mice the activation of D4Rs
may have an inhibitory influence on pyramidal neurons of the FC.
MATERIALS AND METHODS
D4 R-deficient mice. All animals tested were originally derived from F1
Drd41/2 mice (C57BL/6J,129/Ola) back-crossed for five successive gen-
erations to produce N5-incipient congenic C57BL/6J mice. Details re-
garding the targeted mutagenesis and generation of these mice have been
described elsewhere (Rubinstein et al., 1997). Heterozygous N5 mice
were bred to obtain wild-type and homozygous mutant mice. Animals
were housed in same-sex groups of five or six with ad libitum access to
food and water. In all experiments, D4R-deficient mice and their wild-
type controls were age and sex matched. The vivarium was maintained at
20–22°C on a 12 hr light /dark cycle (lights on at 7:00 A.M.). All
experimental procedures were performed in accordance with the Na-
tional Institutes of Health guidelines for animal research by individuals
that were blind to the animal’s genotype.
Immunohistochemistry. A polyclonal, anti-peptide antiserum was pro-
duced in rabbits against a unique 20-residue sequence (MGNSSATG-
DGGLLAGAGPEC) that is part of the N terminus of the rat D4R and
is predicted to be extracellular. This peptide was chosen with the aid of
IBI-Pustell MacVector DNA-Protein sequence analysis software that
identifies regions of potential antigenicity. The peptide was synthesized
by Peninsula Laboratories (Belmont, CA), purified by HPLC, and con-
jugated to keyhole limpet hemocyanin (Sigma, St. Louis, MO) via the
terminal cysteine residue using the cross-linking reagent, m-maleimido-
benzoyl-N-hydroxysuccinimide (Sigma) as described previously (Ariano
et al., 1997). The specificity of the antiserum was assessed using trans-
fected Chinese hamster ovary cells that stably express full-length, func-
tionally active rat D4Rs (Ariano et al., 1997). Immunofluorescent stain-
ing in mouse brain sections was performed as described previously
(Ariano et al., 1997). The primary antiserum was diluted 1:1000 in PBS
and applied to 10-mm-thick, frozen-fixed sections of mouse brain and
incubated overnight in a moist environment. Unbound anti-D4R anti-
bodies were removed by rinsing in PBS and then applying fluorescently
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Labs, West
Grove, PA; Molecular Probes, Eugene, OR). After a further 1 hr incu-
bation in a moist environment at 4°C, the sections were rinsed again in
PBS and examined using routine epifluorescence. Controls for the im-
munofluorescence staining reaction included omission of the primary
antisera, substitution of preimmune sera, or adsorption challenge of the
primary antisera with peptide before incubation. Examination of the
tissues under conditions that produce epifluorescence was performed by
a trained investigator (M.A.A.) using a Zeiss Photomicroscope 3 that
was equipped with a 100 W Hg burner as the ultraviolet light source.
Data were captured using HP-5 plus black and white film (Ilford,
Ciba-Geigy, Paramus, NJ) and developed using D-19 (Kodak, Rochester,
NY) to increase the contrast of the film negatives. All scoring was done
without previous knowledge of the genotype of an individual mouse.
Electrophysiolog ical recordings. Mice were killed for rapid brain extrac-
tion, the brains were blocked, and rostral cortical tissue was sectioned
coronally (;350 mm thick). Throughout the sectioning process, slices
were bathed in an oxygenated (95% O2, 5% CO2), low-Ca
21, artificial
CSF (ACSF) composed of (in mM): NaCl 130, KCl 3, NaH2PO4 1.25,
MgCl2 5, NaHCO3 26, CaCl2 1, glucose 10. Slices were incubated in
lactated bicarbonate ACSF (as above except CaCl2 2, MgCl2 2, lactate 4)
at 33°C for at least 1 hr before being placed in a Haas-type recording
chamber. In the recording chamber, slices were superfused (1.4 ml/min)
with standard ACSF of the following concentrations (in mM): NaCl 124,
KCl 5, NaH2PO4 1.25, MgSO4 2, NaHCO3 26, CaCl2 2, glucose 10, for
a minimum of 30 min before electrophysiological recording began. Glass
micropipettes filled with 3 M KAc (60–150 MV) were used for recording.
Signals were amplified (Axoclamp-2A; Axon Instruments, Foster City,
CA), displayed on an oscilloscope, and digitized for subsequent com-
puter analysis (pCLAMP6.0.1; Axon Instruments). After a neuron was
impaled, a baseline recording (20–30 min) was obtained to ensure
stability of membrane properties. Only data obtained from neurons with
resting membrane potentials of at least 260 mV and action potentials
exceeding 55 mV (measured from the start of the rapid rising phase to
the peak of the depolarization) were used. All data were obtained from
well impaled neurons in which recordings were made for 1–2 hr. Mem-
brane properties (membrane potential and input resistance) and action
potential amplitude were measured during the baseline recording period.
Current–voltage relationships were obtained by injection of depolarizing
and hyperpolarizing pulses, and the input resistance of the cell was
determined from hyperpolarizing pulses in the linear portion of the
current–voltage plots.
Paroxysmal activity in cortical slices was produced by bath applying the
convulsant agents 4-aminopyridine (4-AP; 100 mM) and bicuculline me-
thiodide. In cortical slices, bath application of 4-AP induces paroxysmal
discharges (Dube et al., 1988). In an effort to eliminate the confounding
effects of inhibitory amino acid release, bicuculline, also a convulsant
agent, was applied in conjunction with the 4-AP. All quantitative mea-
surements were taken 20–40 min after drug application. Cell identifica-
tion was achieved by filling electrodes with 2% biocytin (Sigma) and
injecting it with hyperpolarizing current pulses (0.5 Hz, 0.3–0.6 nA).
Slices were then fixed overnight in 4% paraformaldehyde.
For studies involving voltage clamp, cortical neurons were visualized
in mouse brain slices using infrared video microscopy and differential
interference contrast optics (IR-DIC). Excitatory spontaneous synaptic
activity was measured from visually identified cortical neurons using the
whole-cell patch-clamp technique. Briefly, the membrane potential was
held at 270 mV, and the membrane current was recorded continuously
for a period of 3–6 min in each of two conditions per cell (19 of 22
recordings were at least 5 min in duration). The membrane current was
filtered at 1 kHz and digitized at 200 msec using Fetchex (Axon Instru-
ments). Spontaneous synaptic activity was first recorded in a control bath
solution composed of the following (in mM): NaHCO3 26, NaH2PO4
1.25, NaCl 130, KCl 3, MgCl2 2, CaCl2 2, glucose 10, and bicuculline (10
mM). The potassium channel blocker 4-AP (50 mM) was then added to the
bath solution for ;5 min before a second measurement of spontaneous
synaptic activity from the same cell but in the presence of 4-AP. Spon-
taneous synaptic events were detected off-line using the Mini Analysis
Program (Jaejin Software, Leonia, NJ); the minimum amplitude re-
quired for the detection of an event was set to 5 pA. The internal solution
in all experiments was composed of the following (in mM): Cs-
methanesulfonate 130, TEA-Cl 5, BaCl2 5, NaCl 4, MgCl2 1, CaCl2 0.5,
EGTA 5, ATP 3, GTP 0.3, HEPES 10; biocytin, 0.2%; pH 7.2.
Convulsant effects of bicuculline. To establish a dose–response curve for
bicuculline-induced seizures, (1)-bicuculline (Sigma), prepared fresh
daily in 0.2N HCl and neutralized with 0.4N NaOH to pH 5.0, was
administered intraperitoneally to mice of both genotypes. After bicucul-
line administration, mice were placed individually in a transparent
acrylic box (30 3 21 3 16 cm) where they were monitored by a trained
observer blind to the genotype of the animal. All sessions were also
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videotaped to permit analysis at a later time. Latencies to clonus, “wild”
running, and tonus were recorded. Each observation period was 15 min
in duration.
Electron microscopy. Mice were anesthetized (10 ml/kg of 5% ket-
amine, 1% acepromazine, and 2% xylazine) and then perfused transcar-
dially with a fixative containing 2.5% glutaraldehyde, 0.5% paraformal-
dehyde, and 0.1% picric acid in 0.1 M HEPES, pH 7.3. Whole brains were
immediately harvested and soaked in cold fixative at 4°C overnight. The
following day, 200 mm coronal sections containing the FC were cut with
a Vibratome (Ted Pella, Redding, CA) and washed in buffer. The tissue
was then incubated in a solution of 1% osmium tetroxide, 1.5% potas-
sium ferricyanide for 30 min at room temperature, stained en bloc with
aqueous 0.5% uranyl acetate, dehydrated in alcohol, cleared in propylene
oxide, and embedded in Epon/Spurrs at 60°C overnight. Ultrathin sec-
tions of tissue were cut on an ultramicrotome (RMC, Phoenix, AZ) and
processed for post-embedding glutamate immunocytochemistry. The
glutamate antibody (Arnel, NY), the specificity of which has been de-
scribed previously (Phend et al., 1992; Meshul et al., 1999), was diluted
1:250,000 before use. Sections were viewed and photographed using a
JEOL 1200 EX TEMSCAN electron microscope. Photographs were
taken randomly throughout the neuropil of asymmetrical nerve termi-
nals, most of which synapse on dendritic spines within layer VI of the FC.
Glutamatergic nerve terminals were identified by the accumulation of
gold particles within the presynaptic ending and a prominent postsynap-
tic density. Only those 10 nm gold particles within presynaptic nerve
terminals and associated with the vesicular pool were counted by an
experienced investigator (L.B.K.), without previous knowledge of the
genotype of a given animal. The area of the nerve terminal was deter-
mined using Image Pro Plus software (Media Cybernetics, Silver Spring,
MD). The mean density of gold particles (number of particles per square
micrometers) and the area of the presynaptic terminals (square microme-
ters) were determined for each animal. The data were analyzed using a
one-way ANOVA with the significance level set at p , 0.05.
Electrochemical detection of l-3,4-dihydroxyphenylalanine, DA, and
DOPAC. HPLC-coupled electrochemical detection of L-3,4-
dihydroxyphenylalanine (L-DOPA), DA, and DOPAC was performed
using a Varian 5000 liquid chromatograph coupled to an electrochemical
detector (BAS LC-4C) by an investigator who was blind with respect to
the genotype of the mouse under study. L-DOPA accumulation in the FC
was measured after blocking its conversion to DA using the DOPA
decarboxylase inhibitor m-hydroxybenzylhydrazine (NSD-1015; Aldrich,
Milwaukee, WI). To determine the slope of DOPA accumulation, mice
from both sexes and genotypes received two intraperitoneal injections
separated by 15 min after three different schemes. One group of animals
received saline in both injections, a second group of mice received saline
first and NSD-1015 (100 mg/kg) 15 min later, and a third group of mice
received first NSD-1015 (100 mg/kg) and then 15 min later a second
injection of NSD-1015 (50 mg/kg). The number of mice of each group
was 6. Mice were killed by cervical dislocation 15 min after the second
injection; the FC was immediately removed, weighed, frozen in dry ice,
and kept at 270°C until electrochemical determination of L-DOPA
levels. In the group of mice receiving only saline, DOPAC and DA were
also determined using the same procedure to calculate the DOPAC/DA
ratio as an index of DA turnover.
RESULTS
D4R immunoreactivity is expressed in neurons of the
mouse FC
In both the monkey (Mrzljak et al., 1996) and the rat (Ariano et
al., 1997), the majority of D4R immunoreactivity (D4R-ir) is
found in the FC. Using a polyclonal antiserum, we determined
that the neuroanatomical distribution of D4R-ir in the mouse
brain parallels that reported previously for the rat (Ariano et al.,
1997), with particularly dense staining throughout the prefrontal,
frontal, and sensorimotor cortices (Fig. 1a). No labeling was
detected when either the primary antibody was omitted (data not
shown) or the brain sections were taken from D4R-deficient mice
(Fig. 1b). Within the cortical regions, D4R-ir was found associated
with large-diameter pyramidal neurons in laminas III and V, as
well as smaller, more rounded cells with morphology consistent
with that of interneurons but not glia. At the subcellular level,
D4R-ir appeared along the proximal portions of apical and basilar
dendrites of pyramidal cells. In addition, relatively dense staining
was observed in the neuropil of the cortex and was probably
caused by receptor expression on dendrites as well as local axon
collaterals in the cortex.
Cortical glutamatergic neurons from D4R-deficient
mice display increased excitability
Because D4Rs have been localized to glutamatergic pyramidal
neurons and GABA-containing interneurons of the FC, and D2-
like receptor agonists are known to act as anticonvulsant agents
(Starr, 1996), we investigated the contribution of D4Rs to the
modulation of pyramidal neuron excitability.
Recordings were made from a total of 20 pyramidal neurons
(10 obtained from eight different wild-type mice and 10 from nine
different D4R-deficient mice) located in layers III–V of the FC.
The average membrane resting potentials (274 6 0.7 mV, wild
type vs 275.8 6 1.3 mV, mutant) and action potential amplitudes
(76.5 6 1.8 mV, wild-type vs 78.0 6 1.8 mV, mutant) were similar.
In contrast, the input resistance was significantly higher in the
wild-type compared with the mutant neurons (37.7 6 2.4 MV,
wild-type vs 31.4 6 1.6 MV, mutant; t 5 2.218; df 5 19; p 5 0.032).
After baseline recordings were made, slices were exposed to
100 mM 4-AP, a convulsant agent that can induce paroxysmal
discharges in cortical slices (Mattia et al., 1993). The GABAA
receptor antagonist bicuculline (10 mM) was applied in conjunc-
tion with 4-AP to eliminate the confounding effects of inhibitory
amino acid release. The application of both drugs consistently
evoked paroxysmal discharges in pyramidal neurons from both
the mutant and wild-type mice (Fig. 2a). In most cells, paroxys-
mal discharges occurred after 7 min exposure to 4-AP and bicu-
culline and consisted of an abrupt membrane depolarization and
a burst of action potentials, sometimes followed by an afterhy-
perpolarization. The frequency of paroxysmal discharges in-
creased over time and reached a plateau ;15 min after applica-
Figure 1. D4R immunoreactivity is detectable in frontal cortical pyrami-
dal neurons in wild-type, but not mutant, mice. a, The arrows point to two
cortical pyramidal neurons in a coronal section of wild-type mouse brain
that reacted with the polyclonal antiserum directed against the D4R. b,
Brain section prepared from a D4R-deficient mouse and incubated with
the D4R antiserum.
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tion of 4-AP and bicuculline. All subsequent measurements were
made after this plateau was reached.
Not only did this treatment significantly increase the frequency
of spontaneous discharges in the mutant neurons (0.066 6 0.009/
sec) compared with wild-type neurons (0.039 6 0.009/sec; t 5
22.182; df 5 19; p 5 0.042) (Fig. 2a), but the average duration of
their bursting was consistently longer (2247 6 499 msec) (Fig. 2b,
right trace) than the wild-type response (982 6 109 msec; t 5
22.245; df 5 18; p 5 0.038) (Fig. 2b, lef t trace).
Evidence for the participation of glutamate in the production
of these paroxysmal discharges was provided by 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) (10 mM), a non-NMDA re-
ceptor antagonist that abolished all spontaneous activity when
added to the bath (Fig. 2c). At the conclusion of the recording
session, individual neurons were labeled with biocytin. Subse-
quent light microscopic analysis failed to reveal any gross mor-
phological differences in the appearance of mutant pyramidal
cells compared with their wild-type counterparts (Fig. 2d).
A total of 11 whole-cell voltage-clamp recordings were made
from adult pyramidal neurons (7 obtained from three wild-type
mice and 4 taken from three mutant mice) visualized by infrared
videomicroscopy before recording (Fig. 3a, inset). Biocytin was
routinely included in the patch pipette to further verify the
identity of the cell at a later time (Fig. 3a). Both wild-type and
mutant neurons displayed spontaneous inward currents of vary-
ing amplitudes and frequencies (Fig. 3b) that were mediated by
the activation of non-NMDA glutamate receptors because they
could be blocked by CNQX (data not shown). The neurons from
D4R-deficient mice displayed a small but statistically significant
increase in the frequency of spontaneous events compared with
the wild-type neurons (Fig. 3d, top lef t panel, lef t set of bars) (t 5
2.66; df 5 9; p 5 0.026). In the presence of 50 mM 4-AP, burst
frequency increased in neurons from both wild-type and mutant
mice, but the effect was most pronounced in the latter (Fig. 3d, top
lef t panel, right set of bars) (t 5 3.45; df 5 9; p 5 0.007).
Although the average amplitude of inward currents was not
significantly different between wild-type and mutant neurons, in
either the presence or absence of 4-AP (Fig. 3d, top right panel),
closer inspection of the data revealed two classes of large inward
currents, as defined by amplitude criteria. The first event group
comprised simple inward currents that had amplitudes greater
than the sum of the mean amplitude and twice the SD for any
given data set. Under control conditions the frequency of this
type of current was the same in both genotypes (Fig. 3d, bottom
lef t panel, lef t set of bars) but in the presence of 4-AP was
significantly increased only in the mutant neurons (Fig. 3d, bottom
lef t panel, right set of bars) (t 5 5.42; df 5 9; p , 0.001). The
second large-amplitude event was characterized by a robust in-
ward current (Fig. 3c) that probably corresponded to the parox-
ysmal depolarizations observed in the current-clamp experiments
described above. Again, under control conditions the frequency of
this type of current was the same in both genotypes (Fig. 3d,
bottom right panel, lef t set of bars) but was significantly increased
by 4-AP only in the mutant neurons (Fig. 3d, bottom right panel,
right set of bars) (t 5 2.57; df 5 9; p 5 0.03). The reduced
frequency of these events in the voltage-clamp experiments com-
pared with the current-clamp experiments may be a reflection of
the lower concentration of 4-AP used in the voltage-clamp
studies.
When taken together, these electrophysiological results indi-
cate that cortical excitability is increased in the D4R-deficient
mice, a finding consistent with the hypothesis that in vivo the D4R
acts as an inhibitory modulator of neuronal activity in the FC. To
test this hypothesis, we performed three types of experiments. In
the first, the effect of PNU-101383G (a novel D4R antagonist) on
the electrophysiological activity of cortical pyramidal neurons
from wild-type and D4R-deficient mouse brain slices was evalu-
ated. In the second set of experiments, the D4R-deficient mice
were analyzed with respect to their sensitivity to the convulsant
effects of the GABAA blocker bicuculline. Third, we investigated
whether the cortical output to cortical layer VI was modified in
D4R-deficient mice by performing an ultrastructural analysis of
glutamate terminal immunolabeling.
Figure 2. Intracellular recordings reveal
increased excitability of cortical pyramidal
neurons in D4R-deficient mice. a, Effects of
4-AP (100 mM) and bicuculline (10 mM) on
cortical pyramidal neurons from wild-type
(lef t four traces) and mutant (right four
traces) mice. b, Representative single, faster-
speed traces of paroxysmal depolarizations
from the neurons shown in a. The lef t trace
is from a wild-type neuron, whereas the
trace on the right is from a mutant neuron. c,
The effect of the non-NMDA receptor an-
tagonist CNQX on paroxysmal discharges
evoked by 4-AP and bicuculline in a neuron
from a mutant mouse is shown. The hyper-
polarizing pulses (downward deflections)
used to measure input resistance are shown
in the trace on the right. d, Biocytin-filled
cortical pyramidal cells from wild-type and
mutant mice. The top panel displays three
different magnifications of a wild-type pyra-
midal neuron. The bottom three panels show
similar magnifications of a pyramidal neu-
ron taken from a mutant mouse. The cali-
brations refer to both the top and bottom
panels.
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The D4R antagonist PNU-101387G increases cortical
excitability in cortical slices of wild-type mice
Several putative D4R antagonists exhibiting different ratios of
binding selectivity in comparison to other DA, 5-HT, and nor-
adrenaline receptors have emerged during the last several years,
although their efficacy in vivo is still a matter of controversy
(Tarazi and Baldessarini, 1999). One of these compounds is
PNU-101387G. This D4R antagonist displays moderately high
affinity (Ki 5 3.6 nM) and selectivity for the D4R (Merchant et al.,
1996). More recently PNU-101387G has been shown to prevent
amphetamine sensitization in rats (Feldpausch et al., 1998) and
stress-induced memory deficits in monkeys (Arnsten et al., 2000).
We used PNU-101387G to determine the possible participation
of the D4R in the modulation of the activity of pyramidal neurons
of the FC in normal mouse brain slices. Whole-cell voltage-clamp
recordings were made from nine cortical pyramidal neurons ob-
tained from four wild-type mice. In standard ACSF at a holding
potential of 260 mV, all neurons displayed spontaneous inward
currents of varying frequencies and amplitudes (Fig. 4a). In the
presence of PNU-101387G (10 mM; 3 min exposure duration), six
of nine neurons displayed an increased frequency of spontaneous
inward currents (Fig. 4a). Two neurons did not display changes,
and one neuron showed a decreased frequency of spontaneous
inward currents. As a group, the increase in frequency was
statistically significant (87 6 15.4%; t 5 22.48; df 5 8; p , 0.05)
(Fig. 4b). In the neurons that displayed increases in the frequency
of spontaneous inward currents, we examined normalized ampli-
tude–frequency histograms to determine whether changes in fre-
quency were associated with changes in amplitude. There were no
consistent changes in the normalized amplitude–frequency his-
tograms in the presence of PNU-101387G (Fig. 4c). In the two
neurons that did not change frequency of spontaneous inward
currents in the presence of PNU-101387G, after washing we
subsequently added 4-AP to increase the frequency of spontane-
ous events and then re-exposed the neurons to PNU-101387G 10
mM for 3 min. Both neurons now displayed an increase in fre-
quency (317 and 54%). To provide a test of pharmacological
specificity of the D4R antagonist, we examined the effects of
applying the same concentration of PNU-101387G in five neu-
rons from two D4R-deficient mice. PNU-101387G (10 mM) had
no significant net effect (Fig. 4b): two neurons displayed slight
increases in the frequency of inward currents, and three displayed
decreases. These data indicate that blockade of the D4R can
increase the frequency of spontaneous inward currents,
thereby providing additional support for the hypothesis that
this receptor subtype mediates at least some of inhibitory
actions of DA in the cortex. Furthermore, the observation that
a change in frequency did not appear to be associated with a
change in amplitude suggests that some of these inhibitory
actions may be presynaptic.
D4R-deficient mice are supersensitive to the
convulsant effects of bicuculline
On the basis of the electrophysiological data, we hypothesized
that pyramidal neurons in the FC of D4R-deficient mice might
become hyperexcitable under proconvulsive conditions. To test
this hypothesis, wild-type and mutant mice were exposed to
increasing concentrations of the convulsant bicuculline. At doses
up to 3 mg/kg, bicuculline produced only mild to medium signs of
epileptogenic activity in mice of both genotypes. However, at 4
mg/kg, bicuculline displayed pronounced convulsant effects that
differed as a function of genotype (Fig. 5). After the administra-
tion of 4 mg/kg bicuculline, all of the wild-type mice entered a
tonic–clonic seizure phase that was characterized by a loss of
postural control, barrel rolling, spontaneous jumping, and con-
vulsions. At this dose, 60% of the animals died by the end of the
15 min observation period. In contrast, the mice lacking D4Rs
displayed more pronounced epileptic-like seizure behavior and a
Figure 3. Whole-cell voltage-clamp re-
cordings reveal increased excitation of cor-
tical pyramidal neurons from D4R-deficient
mice. a, An example of a biocytin-filled
pyramidal neuron from a mutant mouse
from which voltage-clamp data were ob-
tained. The inset shows an IR-DIC image
of the cell (arrow) before the patch elec-
trode was attached. Panels show two differ-
ent magnifications of the same pyramidal
neuron. b, Recordings of inward membrane
currents showing excitatory events in a cor-
tical neuron isolated from a wild-type (lef t
traces) and a mutant mouse (right traces).
Currents were recorded either in control
conditions (top traces) or in the presence of
50 mM 4-AP (bottom traces). Bicuculline (10
mM) was present throughout the experi-
ment, and the membrane was held at 270
mV. c, Approximately 5.5 min of mem-
brane current recorded from a neuron pre-
pared from a D4R-deficient mouse in the
presence of 4-AP (50 mM). The five large
downward deflections reflect paroxysmal
activity evoked by the addition of 4-AP to
the bath solution. d, Summary plots of
quantified spontaneous synaptic activity.
Columns indicate the results obtained from wild-type (black) and D4R-deficient mice (white), respectively. d (top lef t panel ), Plot of the frequency (in
Hertz) of all the detected spontaneously occurring events. d (top right panel ), Plot of the mean amplitude of all the detected spontaneous events. d (bottom
lef t panel ), Plot of the frequency of the events greater in amplitude than the sum of the mean amplitude and twice the SD for any given data set (see
Results). d (bottom right panel ), Plot of the frequency (events per minute) of paroxysmal activity.
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significantly earlier onset of tonus, wild running, and clonus (Fig.
5). In addition, all of the D4R-deficient mice experienced severe
seizures and died within 15 min of administration of the
bicuculline.
Glutamate immunoreactivity is decreased in
D4R-deficient mice
Recent in vivo microdialysis and electron microscopic studies
have demonstrated that enhanced extracellular levels of gluta-
mate are correlated with a decrease in the density of terminal
glutamate immunolabeling as a consequence of reduced accumu-
lation of neurotransmitter (Meshul et al., 1999). Given the appar-
ent cortical hyperexcitability that we observed in our mutant
mice, we hypothesized that glutamate immunolabeling of FC
pyramidal neurons might be reduced in the D4R-deficient mice
compared with wild-type cells. To test this hypothesis we per-
formed an ultrastructural analysis of glutamate immunolabeling
in 349 FC terminals, 165 of which came from wild-type mice (n 5
6) (Fig. 6a) and the remaining 184 from D4R-deficient mice (n 5
6) (Fig. 6b). This study revealed significantly less glutamate-ir in
FC layer VI of mutant (91 6 3 SEM gold particles/mm2), com-
pared with wild-type, mice (114 6 4 SEM gold particles/mm2).
DA synthesis and turnover in the FC is unaffected in
mice lacking D4Rs
Because glutamatergic pyramidal neurons of the FC appeared to
be hyperactive in the D4R-deficient mice, we investigated
whether this condition might be associated with altered DA
synthesis and release in this brain region. L-DOPA accumulation
was assessed after treatment with the L-aromatic decarboxylase
inhibitor NSD-1015 to estimate the rate of DA synthesis. The
accumulation of L-DOPA in the FC of wild-type and mutant mice
was similar, with a calculated DA synthesis rate of 2.627 6 0.046
pg/min and 3.010 6 0.345 pg/min in each respective genotype.
The DOPAC/DA ratio was also calculated and found to be
similar between the two genotypes (wild type: 3.26 6 0.71;
mutant: 2.71 6 0.14).
Figure 5. D4R-deficient mice are hypersensitive to the convulsant effects
of the GABAA blocker bicuculline. Shown is the onset of the different
convulsive phases induced by bicuculline (4 mg/kg, i.p.) in wild-type
(black columns) and D4R-deficient (white columns) mice. Bars represent
the mean 6 SEM time values of wild-type (n 5 10) and D4R-deficient
mice (n 5 9), respectively. Data were analyzed by Student’s t test. *p ,
0.05 and **p , 0.005 compared with wild-type mice. Each animal was
observed for 15 min.
Figure 4. The D4R antagonist PNU-
101387G increases the frequency of
spontaneous inward currents in corti-
cal pyramidal neurons in the FC of
wild-type mice but has no effect in
D4R-deficient mice. a, Whole-cell
voltage-clamp recordings. Top trace
shows spontaneous activity before ap-
plication of PNU-101387G. Bottom
trace shows that during application of
the D4 antagonist (10 mM, 3 min ap-
plication) spontaneous inward cur-
rents increased in frequency. b, Bar
graph shows increase in frequency of
spontaneous inward currents in wild-
type mice and return to baseline after
wash. Asterisk indicates that increase
was statistically significant ( p , 0.05).
In D4R-deficient mice there was no
net change in spontaneous inward
currents. c, Amplitude–frequency his-
tograms before (Control ), during, and
after (Wash) exposure to the D4 an-
tagonist in the FC neuron shown in a.
d, Amplitude–frequency histograms
were first normalized to the total
number of events in each of the three
histograms shown in c, and then the
cumulative frequencies were plotted
before (Control ), during, and after (Wash) exposure to the D4 antagonist. The curves superimpose, indicating that although the D4 antagonist
markedly increased the frequency of spontaneous inward currents, their amplitudes were not altered.
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DISCUSSION
The absence of D4Rs leads to increased cortical
excitability and glutamate synaptic activity
On the basis of anatomical studies, it has been proposed that
D4Rs may modulate the activity of cortical neurons (Mrzljak et
al., 1996), and now our electrophysiological analyses, including
current- and voltage-clamp experiments, have demonstrated that
cortical neuronal activity is enhanced in D4R-deficient mice.
There is considerable evidence that DA, acting on multiple re-
ceptor subtypes (Cepeda et al., 1992; Goldman-Rakic, 1996), can
have both excitatory and inhibitory influences on the activity of
neurons in the FC. Furthermore, D1-like agonists are known to
promote seizure activity, whereas D2-like agonists can act as
anticonvulsants, presumably by elevating the excitatory threshold
of the FC (Starr, 1996). In the present study, we found that the
total absence or pharmacological blockade of D4Rs increases
excitability in the FC and that mice lacking D4Rs also have an
increased susceptibility to the tonic–clonic seizures produced by
bicuculline. Therefore, the ability of typical and atypical neuro-
leptics, including clozapine (Denney and Stevens, 1995), to in-
duce paroxysmal discharges may be explained, in part, by their
ability to block D4Rs in the FC. On the basis of these observa-
tions, it is conceivable that selective stimulation of D4Rs may
constitute a rational pharmacotherapy for certain types of epilep-
tic disorders.
Increased cortical excitability and reduced glutamate immuno-
gold labeling in mutant mice are consistent with the interpreta-
tion that D4Rs may normally exert an inhibitory influence on FC
glutamatergic pyramidal neurons in wild-type mice. Alterna-
tively, our findings could be explained by a significant increase in
the activity of ascending dopaminergic mesocortical neurons that
would elevate cortical DA levels and possibly prolong the activa-
tion of D1-like receptors in the D4R-deficient mice. To address
the possibility that the presynaptic component of mesocortical
DA transmission was altered in the D4R mutant mice, we assessed
the rate of DA synthesis and turnover in the FC of wild-type and
receptor-deficient mice. The results of these studies indicated that
in the mutant mice the presynaptic components of DA neuro-
transmission are not altered in the FC, similar to what we ob-
served in the nucleus accumbens of the mutant mice (Rubinstein
et al., 1997), but in marked contrast to what was observed in the
dorsal striatum of these animals. The unaltered synthesis and
turnover of cortical DA in the D4R-deficient mice support the
hypothesis that DA can have an inhibitory influence on cortical
excitability via its postsynaptic actions on D4R-expressing cortical
neurons, some of which may project to the dorsal striatum. This
interpretation may help to explain how some atypical antipsychot-
ics that are also D4R antagonists (Van Tol et al., 1991; Roth et al.,
1995), such as clozapine, can increase neuronal activity in the FC
and ameliorate some cognitive and affective deficits that afflict
schizophrenics without producing the unwanted side effects asso-
ciated with the typical antipsychotics (Lidow et al., 1998).
Recent genetic studies have associated certain alleles of the
human DRD4 gene with the occurrence of ADHD (LaHoste et
al., 1996; Swanson et al., 1998). ADHD, characterized by diffi-
culty with concentration, has been associated with FC malfunc-
tion (Barkley, 1998) and has shown a heritability of 50–90%
(Gillis et al., 1992). Neuroanatomical imaging studies performed
on normal individuals as well as individuals with ADHD have
revealed that the FC, dorsal striatum, and globus pallidus, the
three areas richest in D4Rs (Mrzljak et al., 1996; Ariano et al.,
1997), are significantly smaller in affected individuals compared
with the corresponding structures in control subjects (Castellanos
et al., 1996). Given that individuals suffering from ADHD are
frequently medicated with catecholamine uptake inhibitors such
as methylphenidate, our results are consistent with the interpre-
tation that by indirectly increasing DA levels in the FC, methyl-
phenidate may derive its clinical benefit, in part, by prolonging
the hyperpolarization of pyramidal neurons, perhaps via the
sustained activation of D4Rs.
In conclusion, we have provided behavioral, electrophysiologi-
cal, immunocytochemical, and ultrastructural evidence that cor-
tical activity is elevated in mice lacking D4Rs. We have also
presented pharmacological data that D4R blockade increases
excitability in wild-type pyramidal neurons of the FC. Knowing
that D4Rs are expressed in cortical neurons and that their acti-
vation can result in cellular hyperpolarization, we have concluded
that the abnormal hyperexcitability displayed by cortical neurons
in slices of brain taken from D4R-deficient mice is a consequence
of the inability of DA to exert its normal inhibitory influence over
these neurons. Consequently, we anticipate that future studies
involving these receptor-deficient mutant mice and their wild-type
Figure 6. Ultrastructural analysis of frontal cortex from wild-type and
D4R-deficient mice. Electron photomicrographs of nerve terminals within
the frontal cortex prepared from wild-type (a) and D4R-deficient (b)
mice. In a and b, the small arrows identify gold particles that reveal the
location of the glutamate antibody; the large arrows indicate asymmetrical
synaptic contacts. Scale bar (shown in b for a and b): 0.25 mm.
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counterparts will serve to further illuminate the contributions that
this DA receptor subtype makes to normal brain function.
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